Irofulven in Treating Children With Recurrent or Refractory Solid Tumors
Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
Phase I trial to study the effectiveness of irofulven in treating children with recurrent or
refractory solid tumors. Drugs used in chemotherapy use different ways to stop tumor cells so
they stop growing or die.